Background: Because most hepatitis C virus (HCV) infections are asymptomatic and often
unrecognized, screening for hepatitis C has been proposed as a plausible public health …

Background Hepatitis C is a liver infection caused by hepatitis C virus. Its main
complications are cirrhosis and liver cancer. According to the World Health Organization …

Background: The seroprevalence of hepatitis C virus (HCV) infection among Canadians is
estimated at 0.3% to 0.9%. Of those with chronic HCV infection, 10% to 20% will experience …

Methods A published decision-tree plus Markov model was used to compare the expected
costs and quality-adjusted life years (QALY) between one-time universal HCV screening …

Abstract (See the Editorial Commentary by Deuffic-Burban and Yazdanpanah, on pages
1272–4.) Background. Current US guidelines recommend limiting hepatitis C virus (HCV) …

Hepatitis C virus (HCV) infection is a major cause of cirrhosis and liver cancer, and many
developing countries report intermediate-to-high prevalence. However, the economic impact …

Background Screening for hepatitis C virus (HCV) followed by direct-acting antiviral (DAA)
treatment in individuals born between 1945 and 1964 has been shown to be both effective …

Objectives: To investigate the value of expanding screening and treatment for hepatitis C
virus (HCV) infection in the United States. Study Design: Discrete-time Markov model …

PURPOSE: To estimate the cost effectiveness of screening for hepatitis C in asymptomatic,
average-risk adults. METHODS: We used a Markov decision analysis model to estimate the …

Aim The management of hepatitis C virus (HCV) has changed with the advent of interferon
(IFN)‐free treatment and the declining prevalence of HCV infection, which may impact the …